Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysisFrançois‐Clément Bidard, Paul Cottu, Stefan Michiels et al.|JNCI Journal of the National Cancer Institute|2018Cited by 282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Klaus Pantel, Dieter Peeters et al.|Critical Reviews in Oncology/Hematology|2018Cited by 268
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysisMario Giuliano, Daniele Generali, Francesco Schettini et al.|The Lancet Oncology|2019Cited by 193
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Daniele Generali, Fabiola Giudici et al.|JNCI Journal of the National Cancer Institute|2020Cited by 102
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysisFrancesco Schettini, Daniele Generali, Fabiola Giudici et al.|European Journal of Cancer|2021Cited by 65